Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Sofokast Plus Tablet
Manufacturer/Marketed By : APRAZER HEALTHCARE PVT LTD
$174.20 $24.39
Sofokast Plus tablet contains the active ingredient Daclatasvir. It is an Anti-Viral drug that belongs to a group of medicines called hepatitis C virus (HCV) NS5A inhibitors. It is used along...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
DACLATASVIR,SOFOSBUVIR
Active Pharmaceutical Ingredient
Sofokast Plus Tablet
$174.20
$24.39
Sofokast Plus tablet contains the active ingredient Daclatasvir. It is an Anti-Viral drug that belongs to a group of medicines called hepatitis C virus (HCV) NS5A inhibitors. It is used along with another medication to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). It works by stopping the virus that causes hepatitis C from spreading inside the body. Do not take Sofokast Plus tablet if you are allergic to Daclatasvir or any of the other ingredients. This medicine must always be used in combination with other medicines against hepatitis C infection. Inform your doctor if you have an irregular heartbeat or liver injury before initiating the treatment. Report to your doctor if you have shortness of breath, lightheadedness, palpitations, and fainting while taking this medicine. Sofokast Plus tablet is not recommended for patients below 18 years of age. Do not take this medicine if you are pregnant or breastfeeding. Use effective contraception during the treatment. The common side effects of this treatment are headache, tiredness, anemia, and nausea. Chronic hepatitis C virus
Active Pharmaceutical Ingredient
Uses
• Chronic hepatitis C virus
Benefits
This medicine works by stopping the hepatitis C virus from multiplying and infecting new cells. This lowers the amount of hepatitis C virus in your body and removes the virus from your blood over a period of time.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Nausea
• Headache
• Tiredness
• Dizziness
Common Side Effects
• Decreased heart rate
• Liver failure
• Reactivation of hepatitis B virus
How To Use
It is an orally available prescription drug. Your doctor will decide the dose and duration of Sofokast Plus tablet based on the disease condition and other factors such as body weight and age. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with a glass of water.
Safety Advice
• Breast Feeding: Breastfeeding is not recommended in patients taking Sofokast Plus tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
• Alcohol: It is unknown whether it is safe to drink alcohol while taking Daclatasvir. Consult your doctor for more information
• Liver: Sofokast Plus tablet is safe when administered in patients with liver diseases. Dose adjustments are not necessary. However, inform your physician if you have any liver diseases before initiating the therapy.
• Lungs: It is unknown whether Sofokast Plus tablet is safe to be administered in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.
• Driving: It is unsafe to drive after Sofokast Plus tablet tablets because it may cause dizziness and drowsiness.
• Pregnancy: Do not take Sofokast Plus tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during and for 5 weeks after your last dose.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.